Search
Showing results for "clinical trials"
Hypoglycemia is the commonest acute complication of type 1 diabetes
This study aimed to identify a CIS peripheral blood signature that may provide clues for potential immunomodulatory approaches early in disease
Type 2 inflammation is present in patients during virus-induced asthma exacerbations, to the same degree as non-viral exacerbations
Describing the challenges of obtaining state and nationally held data for linkage to a non-government national clinical registry
The Rare and Undiagnosed Diseases Diagnostic Service refers to a genomic diagnostic platform operating within the Genetic Services of Western Australia
With a focus on the microbiome as it pertains to mental health, we define environmental “grey space” and emphasize a new frontier involving bio-eco-psychological medicine
Improving glycaemic control in people with Type 1 diabetes is known to reduce complications.
We aimed to measure the incidence and severity of invasive Group A Strep disease in the NT since 1996.
To examine follow-up outcomes at corrected postnatal age (cPNA) 2 years of preterm infants previously enrolled in an RCT and treated with IN-REC-SUR-E or IN-SUR-E in 35 tertiary neonatal intensive care units.
Advanced hybrid closed-loop (AHCL) therapy with the Medtronic MiniMed™ 780G system improves glycemia; however, the clinical outcomes in younger children remain less established. This pilot study aimed to explore the continuous glucose monitoring (CGM) metrics in very young children on AHCL. Children between 2 and 7 years of age and on insulin pump therapy were recruited.